G17DT Completed Phase 2 Trials for Colorectal Cancers Treatment

clinicaltrials.gov IdentifierTitleDrugs
NCT02181465Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma.
NCT02518373Effect of G17DT in Patients With Stage II/III Colorectal Cancer
NCT02223078Two Center Study to Determine Effect of G17DT on Plasma Gastrin Levels in Patients With Colorectal Cancer.